Milton C. Ault III - 04 Mar 2022 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
04 Mar 2022
Net transactions value
-$85,524
Form type
4
Filing time
08 Mar 2022, 20:55:29 UTC
Previous filing
03 Mar 2022
Next filing
21 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Other $85,524 -57,016 -0.38% $1.50 14,942,984 04 Mar 2022 By Ault Life Sciences, Inc F1, F2
holding ALZN Common Stock 2,500,000 04 Mar 2022 Direct
holding ALZN Common Stock 7,000,000 04 Mar 2022 By Digital Power Lending, LLC F3
holding ALZN Common Stock 10,000,000 04 Mar 2022 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was transferred in settlement of an aggregate of $85,500 of debt and obligations owed by Ault & Company, Inc. Mr. Ault is the Chief Executive Officer of Ault & Company, Inc.
F2 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F3 Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of BitNile Holdings, Inc. ("BH"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by DPL.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.